Evidence map›Paper›PMID 35301980›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Large-scale decontamination of disposable FFP2 and FFP3 respirators by hydrogen peroxide vapour, Finland, April to June 2020.

Katri Laatikainen, Markku Mesilaakso, Ilpo Kulmala, Erja Mäkelä, Petri Ruutu, Outi Lyytikäinen, Susanna Tella, Tarmo Humppi, Satu Salo, Tuuli Haataja and 10 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Katri LaatikainenDepartment of Separation Science, Lappeenranta-Lahti University of Technology LUT, Lappeenranta, Finland.
Markku MesilaaksoFinnish Defense Research Agency, Ylöjärvi, Finland.
Ilpo KulmalaVTT Technical Research Centre of Finland Ltd, Espoo and Tampere, Finland.
Erja MäkeläFinnish Institute of Occupational Health, Helsinki, Kuopio and Oulu, Finland.
Petri RuutuFinnish Institute for Health and Welfare, Helsinki, Finland.
Outi LyytikäinenFinnish Institute for Health and Welfare, Helsinki, Finland.
Susanna TellaLAB University of Applied Science, Lappeenranta and Lahti, Finland.
Tarmo HumppiFinnish Defense Research Agency, Ylöjärvi, Finland.
Satu SaloVTT Technical Research Centre of Finland Ltd, Espoo and Tampere, Finland.
Tuuli HaatajaFinnish Defense Research Agency, Ylöjärvi, Finland.
Kristiina HelminenLAB University of Applied Science, Lappeenranta and Lahti, Finland.
Henri KarppinenLAB University of Applied Science, Lappeenranta and Lahti, Finland.
Heli KähkönenFinnish Institute of Occupational Health, Helsinki, Kuopio and Oulu, Finland.
Tarja VainiolaFinnish Medicines Agency Fimea, Helsinki, Finland.
Kirsimarja BlomqvistLUT School of Business and Management, Lappeenranta-Lahti University of Technology LUT, Lappeenranta, Finland.
Sirpa LaitinenFinnish Institute of Occupational Health, Helsinki, Kuopio and Oulu, Finland.
Kati PeltonenLAB University of Applied Science, Lappeenranta and Lahti, Finland.
Marko LaaksonenFinnish Defense Research Agency, Ylöjärvi, Finland.
Timo RistimäkiFinnish Defense Research Agency, Ylöjärvi, Finland.
Jouni KoivistoFinnish Defense Research Agency, Ylöjärvi, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundThe shortage of FFP2 and FFP3 respirators posed a serious threat to the operation of the healthcare system at the onset of the COVID-19 pandemic.AimOur aim was to develop and validate a large-scale facility that uses hydrogen peroxide vapour for the decontamination of used respirators.MethodsA multidisciplinary and multisectoral ad hoc group of experts representing various organisations was assembled to implement the collection and transport of used FFP2 and FFP3 respirators from hospitals covering 86% of the Finnish population. A large-scale decontamination facility using hydrogen peroxide vapour was designed and constructed. Microbiological tests were used to confirm efficacy of hydrogen peroxide vapour decontamination together with a test to assess the effect of decontamination on the filtering efficacy and fit of respirators. Bacterial and fungal growth in stored respirators was determined by standard methods.ResultsLarge-scale hydrogen peroxide vapour decontamination of a range of FFP2 and FFP3 respirator models effectively reduced the recovery of biological indicators:

Indexed as

COVID-19Hydrogen PeroxideDecontaminationFinlandHumansPandemicsVentilators, MechanicalHydrogen PeroxideFFP2/FFP3 respiratorsH2O2 decontaminationmultidisciplinarymultisectoral collaborationreuse

Identifiers

PMID35301980
PMCPMC8971915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.